What is Ananxyl used for?

Ananxyl is indicated for Anxiety disorder.

What development phase is Ananxyl in?

Ananxyl is FDA-approved (marketed).

What is the generic name of Ananxyl?

ALPIDEM is the generic (nonproprietary) name of Ananxyl.

Last reviewed 2026-04-20 · How we verify

Ananxyl (ALPIDEM)

FDA-approved withdrawn Small molecule Quality 17/100

Alpidem (Ananxyl) is a marketed anxiolytic that binds to the translocator protein to regulate GABA activity, primarily indicated for anxiety disorders. Its key strength lies in its unique mechanism of action, distinguishing it from off-patent competitors like disulfiram. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generics.

At a glance

Generic name	ALPIDEM
Drug class	alpidem
Target	Translocator protein
Modality	Small molecule
Therapeutic area	Neuroscience
Phase	FDA-approved

Approved indications

Anxiety disorder

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ananxyl CI brief — competitive landscape report
Ananxyl updates RSS · CI watch RSS